Trial intelligence / Profile preview

Adjuvant metformin in pubertal children with classic congenital adrenal hyperplasia

2013-002395-40Phase 3Completed

Sponsor
Ghent University Hospital
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of metformin in congenital adrenal hyperplasia (CAH), sponsored by Ghent University Hospital. Primary endpoints: Body composition, Lipid profile and 4 more. Started Nov 2013; status: completed.

02

Drugs

metformin
03

Conditions

congenital adrenal hyperplasia (CAH)

Beyond the preview

Go deeper on 2013-002395-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002395-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call